리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 08월
페이지 정보:영문 196 Pages
라이선스 & 가격 (부가세 별도)
한글목차
종양 절제 기술 세계 시장, 2030년까지 38억 달러 규모에 달할 것으로 전망
2023년에 16억 달러로 추정되는 종양 절제 기술 세계 시장은 2023-2030년 분석 기간 동안 연평균 13.3% 성장하여 2030년에는 38억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 고주파 절제술은 CAGR 13.7%를 기록하여 분석 기간이 끝날 때까지 14억 달러에 도달할 것으로 예상됩니다. 마이크로파 절제 부문은 분석 기간 동안 CAGR 14.4%로 성장할 것으로 예상됩니다.
미국 시장은 4억 2,960만 달러로 추정되며, 중국은 CAGR 12.3%로 성장할 것으로 예상됩니다.
미국의 종양 절제 기술 시장은 2023년 4억 2,960만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년 분석 기간 동안 12.3%의 CAGR로 성장하여 2030년에는 5억 7,420만 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 12.0%와 11.0%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 약 9.5%의 CAGR로 성장할 것으로 예상됩니다.
세계 종양 절제 기술 시장 - 주요 동향 및 촉진요인 정리
종양 절제술이란 무엇이며, 왜 중요한가?
종양 절제술은 극한의 열이나 냉기, 전기 에너지 또는 화학 약품을 사용하여 암 조직을 파괴하는 데 사용되는 최소침습적 치료법입니다. 이러한 기술에는 방사선 소작술(RFA), 마이크로파 소작술, 냉동 소작술, 화학적 소작술 등이 포함됩니다. 종양 소작술은 간, 신장, 폐, 뼈와 같은 장기에 국한된 종양을 치료하는 데 매우 중요하며, 기존의 수술적 방법을 대체할 수 있는 치료법입니다. 이 기술은 회복 시간 단축, 최소침습성, 종양을 정확하게 표적화할 수 있는 능력 등 큰 이점을 제공합니다. 종양 절제술은 수술이 적합하지 않거나 접근하기 어려운 위치에 종양이 있는 환자에게 특히 유용합니다.
기술의 발전은 어떻게 시장을 형성해 왔습니까?
기술의 발전은 종양 절제 기술의 개발과 응용에 큰 영향을 미쳤습니다. 초음파, CT, MRI와 같은 영상 진단 기술의 혁신은 절제술의 정확성과 지침을 향상시켜 종양을 보다 정확하게 표적화할 수 있게 했습니다. 에너지 전달 시스템을 강화한 첨단 절제 장비의 개발은 절제 치료의 효과와 안전성을 향상시키고 합병증 위험을 줄이며 환자 결과를 개선했습니다. 카테터와 프로브 설계의 발전으로 절제 기술의 사용 편의성과 범용성이 향상되어 더 넓은 임상 현장에서 사용할 수 있게 되었습니다. 또한 실시간 모니터링 및 피드백 시스템의 통합으로 절제술의 제어와 효과가 향상되었습니다. 이러한 기술 발전은 종양 절제 기술의 용도와 효능을 확대하여 암 치료에의 도입을 촉진하고 있습니다.
주요 사용자와 그들의 니즈는?
종양 절제술 기술의 주요 사용자는 종양 전문의, 중재적 방사선 전문의, 외과의사 등이 있습니다. 종양 전문의는 종양 절제술을 암 치료의 다학제적 접근의 일환으로 사용하며, 부작용을 최소화하면서 종양을 정확하고 효과적으로 파괴할 수 있는 기술을 찾고 있습니다. 중재적 방사선 전문의는 영상 유도 소작술을 수행하기 위해 정확한 타겟팅과 실시간 모니터링을 제공하는 첨단 영상 진단 및 소작 시스템을 필요로 합니다. 외과 의사들은 외과적 절제술을 보조하거나 외과적 접근이 어려운 종양을 치료하기 위해 신뢰할 수 있고 다재다능한 절제술 장비를 필요로 합니다. 각 사용자 그룹은 환자의 예후를 개선하고 치료 옵션을 넓히기 위해 높은 정확도, 안전성, 유효성을 제공하는 종양 절제 기술을 높이 평가하고 있습니다.
종양 절제 기술 시장의 성장 원동력은 무엇인가?
종양 절제 기술 시장의 성장은 암 발병률 증가, 절제 기술의 발전, 최소침습적 치료에 대한 수요 증가 등 여러 가지 요인에 기인합니다. 전 세계적으로 암 발병률이 증가함에 따라 효과적이고 덜 침습적인 치료 옵션에 대한 수요가 증가하고 있으며, 이는 종양 절제 기술의 채택을 촉진하고 있습니다. 영상 유도, 에너지 전달 시스템, 기기 설계 개선 등 절제 기술의 발전은 절제술의 안전성과 유효성을 향상시켜 시장 성장을 뒷받침하고 있습니다. 회복 시간 단축, 합병증 발생률 감소, 환자 편의성 향상 등의 장점으로 인해 최소침습적 치료에 대한 수요가 증가하면서 종양 절제술의 채택을 더욱 촉진하고 있습니다. 또한, 의료진과 환자들 사이에서 절제술에 대한 인식과 수용도가 높아짐에 따라 종양 절제술 시장의 성장을 촉진하고 있습니다.
조사 대상 기업 예시(46개사)
AngioDynamics, Inc.
Boston Scientific Corporation
BTG International Ltd.
EDAP TMS SA
Galil Medical Ltd.
HealthTronics, Inc.
Medtronic PLC
Mermaid Medical A/S
Misonix, Inc.
NeuWave Medical, Inc.
SonaCare Medical LLC
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 성장 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global Tumor Ablation Technologies Market to Reach US$3.8 Billion by 2030
The global market for Tumor Ablation Technologies estimated at US$1.6 Billion in the year 2023, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2023-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Microwave Ablation segment is estimated at 14.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$429.6 Million While China is Forecast to Grow at 12.3% CAGR
The Tumor Ablation Technologies market in the U.S. is estimated at US$429.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$574.2 Million by the year 2030 trailing a CAGR of 12.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.
What Are Tumor Ablation Technologies and Why Are They Crucial?
Tumor ablation technologies are minimally invasive procedures used to destroy cancerous tissues by applying extreme heat or cold, electrical energy, or chemical agents. These technologies include radiofrequency ablation (RFA), microwave ablation, cryoablation, and chemical ablation. Tumor ablation is crucial for treating localized tumors in organs such as the liver, kidney, lung, and bone, offering an alternative to traditional surgical methods. These technologies provide significant benefits, including reduced recovery time, minimal invasiveness, and the ability to target tumors with precision. Tumor ablation is particularly valuable for patients who are not candidates for surgery or those with tumors in difficult-to-reach locations.
How Have Technological Advances Shaped the Market?
Technological advances have significantly influenced the development and application of tumor ablation technologies. Innovations in imaging techniques, such as ultrasound, CT, and MRI, have improved the accuracy and guidance of ablation procedures, allowing for more precise targeting of tumors. The development of advanced ablation devices with enhanced energy delivery systems has increased the efficacy and safety of ablation treatments, reducing the risk of complications and improving patient outcomes. Advancements in catheter and probe design have improved the ease of use and versatility of ablation technologies, enabling their use in a wider range of clinical settings. Additionally, the integration of real-time monitoring and feedback systems has enhanced the control and effectiveness of ablation procedures. These technological advancements have expanded the applications and effectiveness of tumor ablation technologies, driving their adoption in cancer treatment.
Who Are the Key Users and What Are Their Needs?
The key users of tumor ablation technologies include oncologists, interventional radiologists, and surgeons. Oncologists use tumor ablation as part of a multidisciplinary approach to cancer treatment, seeking technologies that offer precise and effective tumor destruction with minimal side effects. Interventional radiologists perform image-guided ablation procedures, requiring advanced imaging and ablation systems that provide accurate targeting and real-time monitoring. Surgeons utilize ablation technologies as an adjunct to surgical resection or for treating tumors that are difficult to access surgically, demanding reliable and versatile ablation devices. Each user group values tumor ablation technologies that offer high precision, safety, and effectiveness to improve patient outcomes and expand treatment options.
What Is Driving Growth in the Tumor Ablation Technologies Market?
The growth in the tumor ablation technologies market is driven by several factors, including the increasing prevalence of cancer, advancements in ablation technologies, and the rising demand for minimally invasive treatments. The growing incidence of cancer worldwide has increased the need for effective and less invasive treatment options, driving the adoption of tumor ablation technologies. Advancements in ablation technologies, including improvements in imaging guidance, energy delivery systems, and device design, have enhanced the safety and efficacy of ablation procedures, supporting market growth. The rising demand for minimally invasive treatments, driven by the benefits of reduced recovery time, lower complication rates, and improved patient comfort, has further fueled the adoption of tumor ablation technologies. Additionally, increasing awareness and acceptance of ablation treatments among healthcare professionals and patients have supported the growth of the tumor ablation technologies market.
Select Competitors (Total 46 Featured) -
AngioDynamics, Inc.
Boston Scientific Corporation
BTG International Ltd.
EDAP TMS SA
Galil Medical Ltd.
HealthTronics, Inc.
Medtronic PLC
Mermaid Medical A/S
Misonix, Inc.
NeuWave Medical, Inc.
SonaCare Medical LLC
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Tumor Ablation Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Prevalence of Cancer
Advancements in Imaging and Guidance Systems
Growth in Minimally Invasive Treatment Options
Impact of Technological Innovations in Ablation Devices
Development of Combination Therapies
Rising Adoption of Outpatient Procedures
Expansion of Radiofrequency and Microwave Ablation
Innovations in Cryoablation and Laser Ablation Technologies
Increasing Focus on Patient Safety and Treatment Efficacy
Growth in Clinical Research and Trials
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Tumor Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Tumor Ablation Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Radiofrequency Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Cryoablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Tumor Ablation Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 26: World Recent Past, Current & Future Analysis for Irreversible Electroporation Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Irreversible Electroporation Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Irreversible Electroporation Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Kidney Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 50: Japan Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
CHINA
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 56: China Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 62: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Tumor Ablation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Europe 16-Year Perspective for Tumor Ablation Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
FRANCE
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 71: France Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: France Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: France 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 74: France Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: France Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: France 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 77: Germany Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Germany Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Germany 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 80: Germany Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Germany Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Germany 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 83: Italy Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Italy Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Italy 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 86: Italy Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Italy Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Italy 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 89: UK Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: UK Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: UK 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 92: UK Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: UK Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: UK 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of Europe Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of Europe 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 107: Rest of World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Rest of World Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Rest of World 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
TABLE 110: Rest of World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Rest of World Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Rest of World 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030